Showing results (1-10 of 126) with videos related to
Sort By:
Pageof 13
Current Opinion in HIV and AIDS|May 14, 2013
Advances in antiretroviral therapyJose R Arribas, Joseph EronThe Journal of Antimicrobial Chemotherapy|July 30, 2004
The rise and fall of triple nucleoside reverse transcriptase inhibitor (NRTI) regimensJose R ArribasCurrent Opinion in HIV and AIDS|January 6, 2010
Drugs in traditional drug classes (nucleoside reverse transcriptase inhibitor/nonnucleoside reverse transcriptase inhibitor/protease inhibitors) with activity against drug-resistant virus (tipranavir, darunavir, etravirine)Jose R ArribasCurrent HIV/AIDS Reports|February 25, 2012
Protease inhibitor monotherapy: what is its role?Miriam Estébanez, Jose R ArribasCurrent Opinion in Infectious Diseases|December 15, 2010
Protease inhibitor monotherapyIgnacio Pérez-Valero, Jose R ArribasBMJ (Clinical Research Ed.)|December 11, 2025
How recent is recent? Retrospective analysis of suspiciously timeless citationsAlejandro Díez-Vidal, Jose R ArribasFamily Process|February 21, 2016
Narrative Solutions: Using Preferred View of Self to Motivate Individual and Family ChangeThomas Lund, Joseph Eron, Steve DagirmanjianThe Journal of Antimicrobial Chemotherapy|March 30, 2010
Unmet therapeutic needs in the new era of combination antiretroviral therapy for HIV-1Babafemi Taiwo, Charles Hicks, Joseph EronExpert Opinion on Drug Safety|December 5, 2017
A safety evaluation of raltegravir for the treatment of HIVRosa de Miguel, Rocio Montejano, Natalia Stella-Ascariz, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in RealityLaura Waters, Rosa de Miguel-Buckley, Sébastien Poulin, et al.Pageof 13